Ohr
Pharmaceutical Inc. (Nasdaq: OHRP) presented additional positive data from
the IMPACT study interim analysis at the 38th Annual Macula Society
Meeting. The stock price leaped $2.09 to close at $9.78.
Ohr presents additional positive study data
March 02, 2015 at 16:04 PM EST